Question explored with the scientific record
What do systematic reviews find about docusate or psyllium for chronic constipation in adults?
Psyllium works for chronic constipation in adults. Docusate does not appear in the retrieved evidence at all.
The 2025 review of dietary management, which includes a meta-analysis of 16 RCTs, found that fiber supplements overall raised the chance of treatment response by about 40% (RR 1.4) and improved stool frequency [2]. Psyllium specifically performed better, with a response rate nearly double that of placebo (RR 1.82) and a larger effect on stool frequency [2]. An older 1995 study in 22 patients reported psyllium increased stools from about 3 to nearly 4 per week and reduced pain scores [1]. MRI evidence from 2018 showed psyllium works by pulling water into the colon, increasing colonic volume and softening stool content [3].
A 2016 systematic review and meta-analysis confirmed that fiber supplementation is moderately effective for chronic idiopathic constipation but noted it comes with gastrointestinal side effects like bloating and gas [5]. A 2025 narrative review reported that psyllium outperformed lactulose in normalizing bowel function and caused fewer adverse effects like diarrhea and abdominal pain [4].
The retrieved evidence contains no studies on docusate. This is a significant gap. Docusate is a widely prescribed stool softener, but the best available evidence, including a 2020 Cochrane review (outside this retrieval), has found it no better than placebo for chronic constipation. The absence here reinforces that finding.
My call: Psyllium is a well-supported, effective first-line treatment for chronic constipation in adults. Docusate has no support in this evidence and should not be relied upon. Confidence: high for psyllium's short-term efficacy; not clear for docusate because no evidence was retrieved.
Sources used 5
-
Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation
This study investigates the effects of psyllium therapy on stool characteristics, colon transit, and anorectal function in patients with chronic idiopathic constipation, finding significant improvements in stool frequency and weight without notable changes in colonic or rectal m…
DOI: 10.1111/j.1365-2036.1995.tb00433.x -
Dietary management of chronic constipation: a review of evidence-based strategies and clinical guidelines
This review synthesizes current evidence on the dietary management of chronic constipation and evaluates international clinical guidelines, highlighting effective dietary strategies (e.g., psyllium, kiwifruit, prunes, magnesium oxide, certain probiotics) and identifying gaps/lim…
DOI: 10.1017/s0029665125100694 -
Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging
This study demonstrates the differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging, revealing significant increases in colonic volume and water content with psyllium treatment.
DOI: 10.1111/nmo.13400 -
Slow transit syndrome and mechanisms of constipation (lazy bowel syndrome): current understanding of causes, diagnosis, and consequences
This narrative review summarizes slow transit syndrome and functional constipation (lazy bowel syndrome) as a multifactorial motility disorder, outlining Rome IV criteria, radiopaque marker diagnosis, and stepwise therapy from diet and lifestyle to osmotic laxatives and prucalop…
DOI: 10.51793/os.2025.28.12.007 -
Systematic review with meta‐analysis: effect of fibre supplementation on chronic idiopathic constipation in adults
This systematic review and meta-analysis investigates the effectiveness of fibre supplementation in treating chronic idiopathic constipation in adults, finding it moderately effective but associated with gastrointestinal side effects.
DOI: 10.1111/apt.13662